Development of a Long-Term Ascending Urinary Tract Infection Mouse Model for Antibiotic Treatment Studies
- 1 January 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (1) , 156-163
Abstract
A model of ascending unobstructed urinary tract infection (UTI) in mice was developed to study the significance of the antibiotic concentration in urine, serum, and kidney tissue for efficacy of treatment of UTI in general and pyelonephritis in particular. Outbred Ssc-CF1 female mice were used throughout the study, and Escherichia coli was used as the pathogen. The virulence of 11 uropathogenic E. coli isolates and 1 nonpathogenic laboratory E. coli strain was examined. Strain C175-94 achieved the highest counts in the kidneys, and this strain was subsequently used as the infecting organism. The model gave reproducible bladder infections, i.e., bacteria were recovered from 22 of 23 control mice after 3 days, and histological examination of kidney tissue showed that of 14 infected kidneys, 7 (50%) showed major histological changes, whereas 3 of 36 uninfected kidneys showed major histological changes ( P = 0.018). Once the model was established, the efficacies of different doses of cefuroxime and gentamicin, corresponding to active concentrations in urine only or in urine, serum, and kidney tissue simultaneously, were examined. All cefuroxime doses resulted in significantly lower counts in urine than control treatments, but the dose which produced concentrations of cefuroxime only in urine and not in serum or kidney tissue had no effect on kidney infection. Even low doses of gentamicin (0.05 mg/mouse) resulted in concentrations in renal tissue for prolonged times due to accumulation. All gentamicin doses had a significant effect (compared to the effect of the control treatment) on bacterial counts in urine and kidneys. The antibiotic effect on bacterial counts in bladders was negligible for unknown reasons. Use of the mouse UTI model is feasible for study of the effect of an antibiotic in the urinary system, although the missing antibacterial effect in the bladder needs further evaluation.Keywords
This publication has 33 references indexed in Scilit:
- Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coliScience, 1998
- Diagnosis and Drug Treatment of Acute PyelonephritisDrugs, 1992
- Urinary tract infections in the 90s: Pathogenesis and managementInfection, 1992
- Enhanced siderophore production and mouse kidney pathogenicity in Escherichia coli grown in urineJournal of Medical Microbiology, 1991
- Short-Term Treatment of Uncomplicated Lower Urinary Tract Infections in WomenClinical Infectious Diseases, 1990
- Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritisKidney International, 1986
- The Pneumococcus and the Mouse Protection Test: Importance of the Lag Phase in vivoChemotherapy, 1983
- Intrarenal antibiotic distribution in health and diseaseKidney International, 1974
- THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELSMedicine, 1965
- The Distribution of Radioactive Cobalt in PigsBritish Journal of Nutrition, 1949